What Is on the Shelf: Femtech, Self-Pleasure and the Limits of Buying Your Way Out

Start with the object, because the object is where Japan did something original.

In 2013 a Japanese company that had made its name selling men’s products launched a line for women built around an unusual proposition: that the barrier was not function but context. The products were made of soft silicone in muted colours, shaped like nothing in particular, and packaged like skincare. They looked like objects a person would be content to leave on a shelf.

Then they were sold in general lifestyle retailers — the kind of large, bright, entirely unembarrassing shop where a person buys a notebook, a candle and a phone case.

That is the innovation, and it is worth being precise about what it solved. The obstacle to a Japanese woman buying one of these things was never that the available products did not work. It was the doorway: the shop she would have to enter, the assumptions attached to entering it, and the possibility of being seen doing so. Redesign the object well enough and a mainstream retailer will stock it, and the doorway disappears.

Nobody outside Japan had approached it that way, and the reason the comparison is interesting is that the West was solving the same problem at the same time by an entirely different route.

The Western route through the two-thousands and twenty-tens was technology and privacy.

A wave of companies differentiated on engineering — new mechanisms of stimulation, new claims about what the device did that older devices could not — and sold direct to the customer online. The proposition was novelty plus invisibility: something genuinely new, delivered in a plain box, ordered from a phone at midnight.

That solves the doorway problem by removing the doorway. Japan solved it by making the doorway ordinary.

Both worked, and the difference between them says something about each market. The Western approach is well suited to a culture comfortable with explicit claims and direct-to-consumer marketing, where a brand can talk frankly about what a product does. The Japanese approach suits a market where the object’s appearance in a shared space matters, where a thing’s design signals what kind of person owns it, and where a category can be normalised by being placed next to the stationery rather than by being argued for.

And the Japanese route has a consequence the other lacks: it made these objects socially visible in a way that private e-commerce does not. A product on a shelf in a well-lit shop is a public statement that this is an ordinary thing to own. A discreet package is a private accommodation with continuing shame.

Before any of that could work, there was a vocabulary problem, and the industry addressed it deliberately.

The existing Japanese words for what these products are for carried heavy connotations — furtive, faintly pathetic, male-coded. There was no available neutral term a woman could use about herself without wincing.

So the industry promoted a borrowed one: セルフプレジャー, self-pleasure, imported into Japanese as a phrase with no accumulated shame attached. It appeared in marketing, in surveys the companies themselves commissioned and publicised, and then gradually in ordinary media coverage.

The same manoeuvre built the wider category. フェムテック entered Japanese public vocabulary around 2020 and 2021 and did something no Japanese phrase could have done: it made an entire domain discussable by making it sound like technology and business. A television programme can cover femtech. A government ministry can fund femtech. Neither could have done the same thing under a Japanese word that named the body parts involved.

This Library has been critical of exactly this manoeuvre elsewhere — the women-facing service sector borrowed clinical vocabulary to escape an unusable one, and that borrowing misleads clients about what is on offer. It is worth saying plainly that this case is different and the difference is instructive. Borrowing a register to escape shame is benign when the borrowed word does not claim a competence nobody has. “Self-pleasure” promises nothing false. “Therapist” does.

The most surprising fact in this subject is governmental, and it does not fit the picture most people hold of Japan.

From 2021 a Japanese ministry ran a support programme for femtech and related services, funding demonstration projects aimed at addressing women’s health barriers to work. A national government allocated money to this category, under that name, and said so publicly.

Around the same period several other things moved. Period poverty became a public issue and local governments began distributing free sanitary products. Online prescription of contraceptive pills expanded substantially. And emergency contraception, long available only through a doctor, began a limited trial of over-the-counter availability at selected pharmacies from late 2023.

Absorbent underwear moved from novelty to ordinary retail in about two years, with domestic brands establishing themselves quickly and department stores giving them space.

Taken together this is a real shift, and it happened fast. The category went from unnameable to state-supported inside roughly five years.

Now the fact that puts all of it in proportion, and it is the reason this essay is not a celebration.

Japan approved oral contraceptives for general use in 1999 — roughly four decades after they became available in comparable countries. The application had been pending for many years. During the same period, an erectile dysfunction drug for men was reviewed and approved on a dramatically shorter timetable. The contrast was noticed at the time, was widely discussed, and has never been satisfactorily explained by anything other than what it appears to show about whose difficulties were treated as urgent.

Uptake of the pill in Japan remains low by international comparison. Abortion sits under a legal framework that has included spousal consent provisions, a requirement with few parallels in comparable countries. Emergency contraception reached pharmacy shelves as a limited trial, decades after equivalent access elsewhere.

So the accurate picture is this: a woman in Japan can now buy a beautifully designed self-pleasure object in a mainstream shop, track her cycle in one of the world’s longest-running period apps, order contraception to her home, and wear absorbent underwear from a domestic brand with a proper marketing budget — inside a legal framework on reproduction that is decades behind the countries those products are sold alongside.

The market moved. The law largely did not. That gap is the single most important thing to understand about Japanese femtech.

There is one further fact that exposes the limits of the product solution better than any other, and it is not widely known outside Japan.

Japanese labour law has provided for menstrual leave since 1947. It is one of the earliest such provisions anywhere in the world, it has been on the books for the better part of eighty years, and take-up is negligible.

The reason is not that Japanese women do not need it. The reason is that claiming it requires telling a manager, usually a man, what it is for. The right exists; the disclosure cost makes it unusable.

This is the clearest available demonstration that the problem was never primarily one of provision. A country can legislate an entitlement and watch it go unused for eight decades because the social conditions for exercising it were never built. And no product addresses this. Absorbent underwear is excellent and it does not make it easier to tell your section chief why you need the afternoon.

Which is the general shape of what femtech can and cannot reach. It is extremely good at things a person can buy privately and use alone. It is powerless against anything requiring another person to behave differently.

It is clarifying to sort the category by the problem each part addresses, because the sorting reveals the shape of the hole.

Information. Cycle-tracking applications, of which Japan has one of the world’s oldest and most heavily used, plus online consultation services. These address a genuine deficit created by constrained school teaching, and they address it well.

Access. Online pill prescription and delivery, pharmacy availability of emergency contraception. These solve logistics and the discomfort of the clinic doorway, which for many women is the binding constraint rather than cost.

Comfort and management. Absorbent underwear, menstrual cups, the broader femcare range. These solve real physical problems that were previously solved worse.

Shame and context. The design-led self-pleasure category, which is the Japanese speciality described above.

And then the hole. Nothing in the category addresses being touched by another person, being wanted by somebody specific, or being attended to. This is not a criticism — no product can do those things, and the industry has never claimed otherwise. But a market’s product mix is a map of what it believes it can solve, and the empty region on that map is exactly the region this Library keeps finding when it looks anywhere else.

A woman can now assemble, entirely from retail, a complete set of solutions to every part of this domain except the part that requires somebody else to be present.

One caution belongs here, because the category has a soft edge where the standards drop.

Alongside the products with clear function sits a broader femcare and wellness range making vaguer claims — about balance, about circulation, about detoxification, about warming. Some of it is harmless and pleasant. Some of it makes claims about what it does to the body that are not supported, and a few practices in this space, including steaming treatments applied to the vulva and vagina, have no evidential basis and carry a real risk of burns and of disturbing normal tissue conditions.

The rule this Library applied to an earlier subject applies here without modification. A product that makes you feel cared for is doing something real and does not need a physiological claim to justify it. A product that asserts it rebalances or detoxifies something is making a testable claim, and those claims generally fail.

The distinction matters commercially as well as ethically, because the credibility of the whole category depends on it. The femtech products with clear function — contraceptive access, cycle data, absorbent textiles — are genuinely good. They are the ones that suffer when the same shelf carries something that cannot survive a question.

On what is locally distinctive, several things here are genuinely unusual when viewed from elsewhere.

The retail context is the first and largest. A mainstream, brightly lit, family-frequented lifestyle chain carrying a self-pleasure range beside the cosmetics is not a common arrangement internationally, and visitors reliably find it surprising.

The asymmetry underneath it is the second, and it is more revealing. Men’s products in Japan were normalised in ordinary retail well before women’s, and reached that position without requiring a design revolution to earn it. The women’s category had to become beautiful to be allowed on the shelf. Nobody asked the men’s category to be beautiful first.

Love hotels are the third, and they are so ordinary domestically that their strangeness is invisible from inside. A dense national infrastructure of private, anonymous, by-the-hour rooms, openly signposted and used by couples across every demographic, has no real equivalent in most countries, and it quietly solves a privacy problem that elsewhere goes unsolved.

And the fourth is print. Japan’s female-facing erotic comics market has functioned for decades as a de facto channel for information and imagination in a country whose schools do not teach the subject. The products on the shelf are recent. The reading material was there the whole time.

The counter-argument to all of this needs stating plainly, because the celebratory version is the one in circulation.

Femtech is a market category. It is not a movement, it has no programme, and it solves what can be profitably sold to people who can pay. Period poverty in Japan was addressed by local governments distributing free products, not by a startup, because the people affected by it were by definition not a market.

There is also a specific risk in a culture already heavy with expectation. Self-care commercialised has a way of becoming one more domain of performance — another set of things a woman is supposed to be doing properly, another axis on which she can be found wanting. A shelf of products for managing your body better is an improvement over silence and it can also become a standard. The women most exhausted by expectation are not obviously helped by adding a category in which they can now also be underperforming.

And most importantly: buying something is not the same as having a right. That is the sentence to take from this essay. A country can have a world-class consumer offering in this domain and a reproductive framework decades out of date, and the first can quietly reduce the pressure for the second, because a population with good products feels less like a population being denied something.

Products are not a substitute for law, and it is worth watching carefully whenever they start to look like one.

The Japanese approval of oral contraceptives in 1999, after a long pending period, and the notably faster review of an erectile dysfunction drug in the same era, are matters of record and were widely discussed at the time. The essay states the contrast and does not assert a single official explanation for it.

Japanese pill uptake being low by international comparison is well established. Specific figures are not quoted here and move over time.

The spousal consent element in Japan’s legal framework around abortion is a matter of law and its practical application varies, including in cases where the provision has been interpreted or waived in specific circumstances. The essay describes the framework rather than the case law.

The over-the-counter emergency contraception arrangement began as a limited trial at selected pharmacies with conditions attached, and its status has continued to develop; anyone acting on this should check current availability rather than rely on this description.

The 1947 menstrual leave provision and its low take-up are documented. The explanation offered — that the disclosure cost makes the right unusable — is the widely given account and is an interpretation rather than a measured finding.

The government femtech support programme from 2021 is a matter of record. Its scale relative to other health spending is not characterised here and should not be inferred.

The account of the design-and-retail route versus the technology-and-privacy route describes the prevailing strategic pattern in each market. Both markets contain counter-examples, and the characterisation is of tendencies rather than a rule.

The caution about steaming treatments applied to the vulva and vagina reflects the absence of supporting evidence and documented reports of harm; it is a general caution and not advice about any specific product.

And no figure for market size, growth or adoption appears anywhere in this essay, because reliable public figures for this category in Japan were not identified.

The most useful way to read a market is to notice what it does not sell.

A Japanese woman can now buy, without embarrassment and in ordinary shops, a solution to nearly every part of this subject. Information about her own cycle. Contraception delivered to her door. Underwear that solves a problem her mother managed worse. An object designed well enough to sit on a shelf, which will reliably do what it is for.

Every one of those is a genuine improvement and none of them requires another person.

What remains unpurchasable is the part that does. Being touched with interest. Being wanted by somebody specific who could have chosen otherwise. Being attended to by a consciousness that is present on purpose. No amount of industrial design reaches it, and the market has been honest about that by simply not offering it.

What this Library can offer is the language for naming that gap without treating it as a defect in you — which is most of what these essays are for.

And an evening in which somebody is paying attention, the terms set in advance and by you, where saying what you want is the activity rather than the risk, and where nothing is inferred from your silence. Not a product, not a solution, and not something you have to be missing anything to deserve.